Terms: = Liver cancer AND TOP2A, TOP2, TP2A AND Diagnosis
21 results:
1. Role of top2a and CDC6 in liver cancer.
Jia W; Liu X; Zhang Z
Medicine (Baltimore); 2023 Oct; 102(42):e35604. PubMed ID: 37861550
[TBL] [Abstract] [Full Text] [Related]
2. [Screening and validation of pivotal genes in hepatitis B virus-associated hepatocellular carcinoma].
Wu YJ; Liu S; Tian YQ; Fan ZJ; Zhang L; Liu SY
Zhonghua Gan Zang Bing Za Zhi; 2023 Aug; 31(8):869-876. PubMed ID: 37723070
[No Abstract] [Full Text] [Related]
3. Identification of ferroptosis and drug resistance related hub genes to predict the prognosis in Hepatocellular Carcinoma.
Li C; Cui X; Li Y; Guo D; He S
Sci Rep; 2023 May; 13(1):8681. PubMed ID: 37248280
[TBL] [Abstract] [Full Text] [Related]
4. Significance of Identifying Key Genes Involved in HBV-Related Hepatocellular Carcinoma for Primary Care Surveillance of Patients with Cirrhosis.
Li Y; Li J; He T; Song Y; Wu J; Wang B
Genes (Basel); 2022 Dec; 13(12):. PubMed ID: 36553600
[TBL] [Abstract] [Full Text] [Related]
5. Custom gene expression panel for evaluation of potential molecular markers in hepatocellular carcinoma.
Pallerla SR; Hoan NX; Rachakonda S; Meyer CG; Van Tong H; Toan NL; Linh LTK; Giang DP; Kremsner PG; Bang MH; Song LH; Velavan TP
BMC Med Genomics; 2022 Nov; 15(1):235. PubMed ID: 36345011
[TBL] [Abstract] [Full Text] [Related]
6. Identification of chromosomal instability-associated genes as hepatocellular carcinoma progression-related biomarkers to guide clinical diagnosis, prognosis and therapy.
Hu Y; Tang C; Zhu W; Ye H; Lin Y; Wang R; Zhou T; Wen S; Yang J; Fang C
Comput Biol Med; 2022 Sep; 148():105896. PubMed ID: 35868048
[TBL] [Abstract] [Full Text] [Related]
7. Integrated Bioinformatics Analysis for the Screening of Hub Genes and Therapeutic Drugs in Hepatocellular Carcinoma.
Su Q; Li W; Zhang X; Wu R; Zheng K; Zhou T; Dong Y; He Y; Wang D; Ran J
Curr Pharm Biotechnol; 2023; 24(8):1035-1058. PubMed ID: 35762549
[TBL] [Abstract] [Full Text] [Related]
8. Identification of novel biomarkers in prostate cancer diagnosis and prognosis.
Li W; Xu W; Sun K; Wang F; Wong TW; Kong AN
J Biochem Mol Toxicol; 2022 Sep; 36(9):e23137. PubMed ID: 35686336
[TBL] [Abstract] [Full Text] [Related]
9. Bioinformatics screening the novel and promising targets of curcumin in hepatocellular carcinoma chemotherapy and prognosis.
Yang T; Chen Y; Xu J; Li J; Liu H; Liu N
BMC Complement Med Ther; 2022 Jan; 22(1):21. PubMed ID: 35078445
[TBL] [Abstract] [Full Text] [Related]
10. Epigenetic and Immune-Cell Infiltration Changes in the Tumor Microenvironment in Hepatocellular Carcinoma.
Wu ZH; Yang DL; Wang L; Liu J
Front Immunol; 2021; 12():793343. PubMed ID: 34925377
[TBL] [Abstract] [Full Text] [Related]
11. Bioinformatic Evidence Reveals that Cell Cycle Correlated Genes Drive the Communication between Tumor Cells and the Tumor Microenvironment and Impact the Outcomes of Hepatocellular Carcinoma.
Chen D; Feng Z; Zhou M; Ren Z; Zhang F; Li Y
Biomed Res Int; 2021; 2021():4092635. PubMed ID: 34746301
[TBL] [Abstract] [Full Text] [Related]
12. Global analysis of gene expression signature and diagnostic/prognostic biomarker identification of hepatocellular carcinoma.
Wang J; Wang Y; Xu J; Song Q; Shangguan J; Xue M; Wang H; Gan J; Gao W
Sci Prog; 2021; 104(3):368504211029429. PubMed ID: 34315286
[TBL] [Abstract] [Full Text] [Related]
13. Bioinformatics Analysis of Candidate Genes and Pathways Related to Hepatocellular Carcinoma in China: A Study Based on Public Databases.
Zhang P; Feng J; Wu X; Chu W; Zhang Y; Li P
Pathol Oncol Res; 2021; 27():588532. PubMed ID: 34257537
[No Abstract] [Full Text] [Related]
14. Integrative analysis identifies key mRNA biomarkers for diagnosis, prognosis, and therapeutic targets of HCV-associated hepatocellular carcinoma.
Zhang Y; Tang Y; Guo C; Li G
Aging (Albany NY); 2021 May; 13(9):12865-12895. PubMed ID: 33946043
[TBL] [Abstract] [Full Text] [Related]
15. Identification of Potential Hub Genes Related to diagnosis and Prognosis of Hepatitis B Virus-Related Hepatocellular Carcinoma via Integrated Bioinformatics Analysis.
Tang Y; Zhang Y; Hu X
Biomed Res Int; 2020; 2020():4251761. PubMed ID: 33376723
[TBL] [Abstract] [Full Text] [Related]
16. Identification of 40S ribosomal protein S8 as a novel biomarker for alcohol‑associated hepatocellular carcinoma using weighted gene co‑expression network analysis.
Bi N; Sun Y; Lei S; Zeng Z; Zhang Y; Sun C; Yu C
Oncol Rep; 2020 Aug; 44(2):611-627. PubMed ID: 32627011
[TBL] [Abstract] [Full Text] [Related]
17. Identification of cancer-related gene network in hepatocellular carcinoma by combined bioinformatic approach and experimental validation.
Ni W; Zhang S; Jiang B; Ni R; Xiao M; Lu C; Liu J; Qu L; Ni H; Zhang W; Zhou P
Pathol Res Pract; 2019 Jun; 215(6):152428. PubMed ID: 31064721
[TBL] [Abstract] [Full Text] [Related]
18. Identification of Potential Key Genes for Hepatitis B Virus-Associated Hepatocellular Carcinoma by Bioinformatics Analysis.
Chen Z; Chen J; Huang X; Wu Y; Huang K; Xu W; Xie L; Zhang X; Liu H
J Comput Biol; 2019 May; 26(5):485-494. PubMed ID: 30864827
[No Abstract] [Full Text] [Related]
19. The Identification of Core Gene Expression Signature in Hepatocellular Carcinoma.
Li N; Li L; Chen Y
Oxid Med Cell Longev; 2018; 2018():3478305. PubMed ID: 29977454
[TBL] [Abstract] [Full Text] [Related]
20. Functional and topological properties in hepatocellular carcinoma transcriptome.
Drozdov I; Bornschein J; Wex T; Valeyev NV; Tsoka S; Malfertheiner P
PLoS One; 2012; 7(4):e35510. PubMed ID: 22539975
[TBL] [Abstract] [Full Text] [Related]
[Next]
